Issuer-Sponsored Content by This Company
(see full disclaimer and compensation information below)
Why I Believe NYSE:VENU Will Be More Explosive Than Quantum, Robotics, A.I. and All the Other Technological Wondermcdougles
My quantum picks were all winners, but now it’s time to go read about VENU!
By Chuck
Senior Financial Editor, WSTPR
- August 25, 2026
Readers,
Back on May 21st, 2025, I published three picks from my “Picking Winners and Losers from the Quantum Realm,” and if you read it and listened, you should probably send me a bottle of champagne.
Rigetti Computing ran from $11 to $58 — that’s a 400% move.
Arqit Quantum moved from $24 to $60 — up 150%.
And D-Wave Quantum, which I showed you at $11, ripped to $46- another 318% winner.
So why am I telling you all this?
Because I believe VENU is setting up for a very similar move, and I don’t want you to miss it.
This isn’t a day trade. VENU is building real assets, including world-class amphitheaters, designed for top promoters, like AEG Presents and others to use for live events, which is one of the fastest growing industries.
These aren’t your typical outdoor venues. They feature climate-controlled amenities, like heated concrete for winter shows, VIP fire pits, advanced sound systems, and a true luxury experience for fans.
The company currently has one VENU open and five more under construction, totaling over $1.1 billion in projects across the country. By 2030, VENU expects to operate 25 amphitheaters and 15 indoor entertainment complexes with a combined capacity of over 350,000 seats. That could translate to more than 20 million annual ticket sales and over $2 billion in projected gross revenue.
This isn’t your typical model. Rather than amortizing the entertainment campuses, VENU’s PPP (8 and 9 figure incentive packages from the local municipalities), Luxe Firepit Suite sales, and leaseback model makes the new properties a very attractive asset that wasn’t built on the shareholders’ backs.
So, when VENU builds a new asset, it gets to quickly book it as such. Plus, this model bends the timeline to profitability way in the shareholders’ advantage.
Take five minutes and pull up the ticker VENU. Read the company’s press releases and look at the images you’ll understand why I’m excited.
Now, here’s the part that gets interesting.
There’s a structural short position in the market of roughly 700,000 shares. Bloomberg data shows 674,000 shares short, down from 734,000. That means my earlier thesis is holding up.
Experienced traders are looking for stocks that have at least 5 days to cover, because they know that forced buy-ins are what power the biggest market moves. WeBull is showing nearly twice that for VENU, which is like lightning in a bottle.
When the company announced its recent $18 funding and closed it two days later at $12, it created a window for bucket-shop institutions to short the stock and try to get shares in the offering. But many were turned away.
They shorted it, but didn’t get stock to cover.
And now VENU is pushing 14!
That’s the imbalance you can see on the chart. With only about 12 million shares in the free float and likely more than half tied up by insiders and institutions the real trading float may be closer to 6 million.
The company was supposed to enter the Russell 3000 earlier this year, but the Russell had to reverse course at the last minute, due to the fact that VENU’s float was too tight.
So, think about what that means.
That means shorts could be holding more than 10% of the available shares.
If those positions start to cover, the buying pressure could be explosive. The Russell 3000 was concerned about the additional exposure causing the stock to explode and now the shorts have gone way past that point.
VENU has been testing the $14 level this past week.
Institutional money came in around $12, so that’s solid support. I’m calling $13 to $15 the Goldilocks zone the sweet spot where I believe the risk-to-reward setup is heavily in our favor.
Traders just need to absorb these shares and give management time to execute. The CEO has been deploying funds strategically and, as new projects are completed, we’ll see a steady stream of catalysts.
Analysts are already bullish. Institutions are accumulating. Once we clear resistance in the mid-$14s, I expect larger funds to step in and support the next leg up.
If the roughly 700,000 shorted shares start getting bought in and with the expected introduction of multiple new VENU locations, the setup could easily send this stock to new all-time highs.
The five projects under construction alone are expected to add over $1 billion to the balance sheet and this is a different company within 12 months.
The Goldilocks zone, between $13 and $15, is where the upside is likely double or more, with limited downside risk. Institutions funded at $12 and that’s your base level of support.
VENU isn’t a microcap it’s a mid-cap company with real assets, a visionary CEO, and a clear roadmap. This setup is as strong as anything I’ve seen this year.
Read the press, and in each WSTPR release there is a link to our full report on the company.
All the best,
Chief Financial Editor
WallStreet PR
DISCLOSURE: WallStreet-PR.com (WSTPR), owns and operates wallstreet-pr.com is a third-party publisher and news release service provider which disseminates corporate news electronically through multiple online media platforms. WSTPR is NOT an affiliate with any of the companies mentioned in our reports. WSTPR is a news distribution service and is not registered with FINRA or any other professional licensing service. WSTPR is not an analyst, broker dealer or advisor, and holds no such licenses. WSTPR may NOT offer to buy, sell, or hold any security. WSTPR corporate profiles will NEVER be a solicitation or recommendation of any kind, of any security mentioned. The materials in all our releases are intended to be for informational purposes only and should never be considered research or due diligence on any company mentioned. All readers are encouraged to perform standard due diligence by reading the company’s filings at SEC.gov. Readers should consult their broker or licensed professional before investing in any company. All materials in this release are based on publicly available statements made by the companies. WSTPR is not liable for any investment decisions made by any readers or subscribers. Any investment could result in you losing all your money from investing in any stock. WSTPR’s editor owns no shares of SYTA restricted shares of Kraig Labs no shares of Venu holdings and no shares of any of the other mentioned companies. The editors of WSTPR can trade in these stocks at any time on news or technical analysis indicators and will not update with position size, entry’s or exits. Trade any of these stocks at your own risk. You should know this is a conflict of interest. Publisher charges $1,000 per editorial press release on WSTPR, and is contracted by Micro Cap Advisory for editorial coverage, and traffic to this web site for Ten Holdings, Venu Holdings and LIXTE biotechnology and could spend up to twenty thousand dollars a week each on investor awareness. WSTPR’s editors have also been contracted to write editorials about Kraig Labs by KAROLUS, who is contracted directly with the company and owns restricted non tradable shares and receives cash compensation for the distribution of this report. WSTPR will also be using financial marketing tools and platform to enhance distribution of this report. WSTPR and its editors own no shares of any other stocks in this editorial and will not be trading in PLANTIR, APPLOVIN, SIYATA or KRAIG unless disclosed herein. Editors are paid to put a best-case scenario profile out to the investing public. This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSTPR undertakes no obligation to update such statements. WallStreetPR.com is a news and opinion website operating under the protections of the First Amendment to the United States Constitution. The content on this site represents the views and opinions of its authors and is intended for informational purposes only. Any sponsored content will be clearly disclosed, and all readers are encouraged to perform their own due diligence before making investment decisions. WallStreetPR does not offer investment advice or securities recommendations.
